Mostrar el registro sencillo del ítem

dc.contributor.authorGómez Regalado, María del Carmen
dc.contributor.authorMartín, Julia
dc.contributor.authorSantos, Juan Luis
dc.contributor.authorAparicio, Irene
dc.contributor.authorAlonso, Esteban
dc.contributor.authorZafra Gómez, Alberto 
dc.date.accessioned2023-06-27T08:13:19Z
dc.date.available2023-06-27T08:13:19Z
dc.date.issued2022-12-05
dc.identifier.citationM.C. Gómez-Regalado et al. Bioaccumulation/bioconcentration of pharmaceutical active compounds in aquatic organisms: Assessment and factors database. Science of the Total Environment 861 (2023) 160638[http://dx.doi.org/10.1016/j.scitotenv.2022.160638]es_ES
dc.identifier.urihttps://hdl.handle.net/10481/82859
dc.description.abstractThere is increasing evidence that the presence of certain pharmaceuticals in the environment leads to biota exposure and constitute a potential risk for ecosystems. Bioaccumulation is an essential focus of risk assessment to evaluate at what degree emerging contaminants are a hazard both to the environment and the individuals that inhabit it. The main goals of the present review are 1) to summarize and describe the research and factors that should be taken into account in the evaluation of bioaccumulation of pharmaceuticals in aquatic organisms; and 2) to provide a database and a critical review of the bioaccumulation/bioconcentration factors (BAF or BCF) of these compounds in organisms of different trophic levels. Most studies fall into one of two categories: laboratory-scale absorption and purification tests or field studies and, to a lesser extent, large-scale, semi-natural system tests. Although in the last 5 years there has been considerable progress in this field, especially in species of fish andmolluscs, research is still limited on other aquatic species like crustaceans or algae. This revision includes >230 bioconcentration factors (BCF) and >530 bioaccumulation factors (BAF), determined for 113 pharmaceuticals. The most commonly studied is the antidepressant group, followed by diclofenac and carbamazepine. There is currently no reported accumulation data on certain compounds, such as anti-cancer drugs. BCFs are highly influenced by experimental factors (notably the exposure level, time or temperature). Field BAFs are superior to laboratory BCFs, highlighting the importance of field studies for reliable assessments and in true environmental conditions. BAF data appears to be organ, species and compound-specific. The potential impact on food web transfer is also considered. Among different aquatic species, lower trophic levels and benthic organisms exhibit relatively higher uptake of these compounds.es_ES
dc.description.sponsorshipMCIN/AEI/10.13039/501100011033/ (grant: PID2020-117641RB-I00)es_ES
dc.description.sponsorshipConsejería de Economía, Conocimiento, Empresases_ES
dc.description.sponsorshipUniversidad (Spanish regional Government of Andalucia)es_ES
dc.description.sponsorshipEuropean funding from ERDF 2014–2020 program (grants B.RNM.362.UGR20 and P20_00556)es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsAtribución-NoComercial 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.subjectEmerging pollutantses_ES
dc.subjectBiotaes_ES
dc.subjectExposurees_ES
dc.subjectBioconcentration factores_ES
dc.subjectBioaccumulation factores_ES
dc.titleBioaccumulation/bioconcentration of pharmaceutical active compounds in aquatic organisms: Assessment and factors databasees_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1016/j.scitotenv.2022.160638
dc.type.hasVersionVoRes_ES


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial 4.0 Internacional